Stock A031390 GREEN CROSS CELL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Green Cross Cell Corporation

Equities

A031390

KR7031390008

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Green Cross Cell Corporation(KOSDAQ:A031390) dropped from S&P Global BMI Index
CI
Green Cross Lab Cell Corporation completed the acquisition of Green Cross Cell Corporation from a group of shareholders.
CI
Green Cross Lab Cell Corporation entered into a definitive merger agreement to acquire Green Cross Cell Corporation from a group of shareholders for approximately KRW 510 billion.
CI
Tranche Update on Green Cross Cell corporation's Equity Buyback Plan announced on March 20, 2019.
CI
Green Cross Cell corporation's Equity Buyback announced on March 20, 2019, has closed with 40,000 shares, representing 0.34% for KRW 2,001.4 million.
CI
Green Cross Cell corporation announces an Equity Buyback for 40,000 shares.
CI
Green Cross Cell corporation authorizes a Buyback Plan.
CI
Sistema, Medsi and RDIF Sign Agreement with South Korean Biotechnology Company Green Cross Cell
CI
An undisclosed buyer cancelled the acquisition of Korea High Tech Co., Ltd. from Green Cross Cell corporation.
CI
Green Cross Cell corporation completed the acquisition of additional 68.8% stake in Lymphotec, Inc. from Toyo Seikan Group Holdings, Ltd..
CI
Green Cross Cell corporation agreed to acquire additional 68.8% stake in Lymphotec, Inc. from Toyo Seikan Group Holdings, Ltd..
CI
Green Cross Cell corporation cancelled the acquisition of CT (cell therapy) business from Green Cross Corporation.
CI
Green Cross Cell corporation announced that it has received KRW 60 billion in funding from a group of investors
CI
AroCell AB Signs Letter of Intent with Green Cross Cell Corporation
CI
Green Cross Cell corporation announced that it expects to receive KRW 60 billion in funding from a group of investors
CI
An undisclosed buyer agreed to acquire Korea High Tech Co., Ltd. from Green Cross Cell corporation for KRW 2.6 billion.
CI
Green Cross Cell corporation's Equity Buyback announced on February 23, 2017, has expired.
CI
Green Cross Cell corporation announces an Equity Buyback.
CI
Green Cross Cell corporation authorizes a Buyback Plan.
CI
Green Cross Cell corporation signed an agreement to acquire CT (cell therapy) business from Green Cross Corporation for KRW 7.9 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A031390 Stock
  4. News Green Cross Cell Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW